William Halter
Director/Board Member at BSR REAL ESTATE INVESTMENT TRUST
Net worth: 1 654 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Oberste | M | - | - | |
| Todd Miller | M | - |
Rave Mobile Safety, Inc.
 Rave Mobile Safety, Inc. Packaged SoftwareTechnology Services Rave Mobile Safety, Inc. provides safety software solutions. It designs and distributes safety applications including emergency notification systems and personal safety tools. The company was founded by Rodger Desai, Ghen Saito and Raju Rishi in 2004 and is headquartered in Framingham, MA. | 17 years |
| Susan Koehn | F | - | 6 years | |
| Todd Piett | M | - |
Rave Mobile Safety, Inc.
Rave Mobile Safety, Inc. Packaged SoftwareTechnology Services Rave Mobile Safety, Inc. provides safety software solutions. It designs and distributes safety applications including emergency notification systems and personal safety tools. The company was founded by Rodger Desai, Ghen Saito and Raju Rishi in 2004 and is headquartered in Framingham, MA. | 19 years |
| Spencer Andrews | M | - | 8 years | |
| Keith Oslakovic | M | - | 22 years | |
| Mani Sundaram | M | 48 | 17 years | |
| Adam Karon | M | 52 | 20 years | |
| Graham Senst | M | 75 | 6 years | |
| Teresa Neto | F | - | 2 years | |
| Steven Etchison | M | - | 7 years | |
| Marianne T. Armstrong | M | 69 | 22 years | |
| S. Marshall | M | 67 | 2 years | |
| Bryan Held | M | 74 | 6 years | |
| Pamela Willrodt | F | - |
State of Arkansas
| - |
| Chris Turnage | M | - |
State of Arkansas
| - |
| Eugene Tyree | M | - |
State of Arkansas
| - |
| Janice Church-Jackson | F | - |
State of Arkansas
| - |
| Chad Stanley | M | - |
State of Arkansas
| - |
| Greg Cheshier | M | - |
State of Arkansas
| - |
| Randy Minton | M | - |
State of Arkansas
| - |
| Brady Banta | M | - |
State of Arkansas
| - |
| Doug Wasson | M | - |
State of Arkansas
| - |
| Shawn Gorham | M | - |
State of Arkansas
| - |
| Becky Lewallen | F | - |
State of Arkansas
| - |
| Charles Snapp | M | - |
State of Arkansas
| - |
| James R. Swartz | M | - |
Stanford University
| 26 years |
| Robert Burke | M | 69 |
Rave Mobile Safety, Inc.
Rave Mobile Safety, Inc. Packaged SoftwareTechnology Services Rave Mobile Safety, Inc. provides safety software solutions. It designs and distributes safety applications including emergency notification systems and personal safety tools. The company was founded by Rodger Desai, Ghen Saito and Raju Rishi in 2004 and is headquartered in Framingham, MA. | 5 years |
| Phillip Anders | M | - | 22 years | |
| Randall Livingston | M | 70 |
Stanford University
| 23 years |
| Bob Davoli | M | 76 |
Rave Mobile Safety, Inc.
Rave Mobile Safety, Inc. Packaged SoftwareTechnology Services Rave Mobile Safety, Inc. provides safety software solutions. It designs and distributes safety applications including emergency notification systems and personal safety tools. The company was founded by Rodger Desai, Ghen Saito and Raju Rishi in 2004 and is headquartered in Framingham, MA. | - |
| Jeff Standridge | M | - |
State of Arkansas
| 9 years |
| Gal Peleg | M | - |
Rave Mobile Safety, Inc.
Rave Mobile Safety, Inc. Packaged SoftwareTechnology Services Rave Mobile Safety, Inc. provides safety software solutions. It designs and distributes safety applications including emergency notification systems and personal safety tools. The company was founded by Rodger Desai, Ghen Saito and Raju Rishi in 2004 and is headquartered in Framingham, MA. | - |
| W. Hughes | M | 58 | 6 years | |
| Mari Baker | F | 59 |
Stanford University
| 28 years |
| W. Asa Hutchinson | M | 73 |
State of Arkansas
| 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel A. Fernandes | M | 54 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | - |
| Daniel Welch | M | 66 | 12 years | |
| Phillip Merrick | M | 61 |
Software AG USA, Inc.
 Software AG USA, Inc. Packaged SoftwareTechnology Services Software AG USA, Inc. provides infrastructure software solutions. It serves the banking, education, energy, insurance, retail, and telecommunication sectors. The company is headquartered in Reston, VA. | 8 years |
| Frederic Salerno | M | 81 | 19 years | |
| Michael S. Ostrach | M | 72 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 1 years |
| Benjamin Chelf | M | - |
Stanford University
| 6 years |
| Stewart M. Kroll | M | 65 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 11 years |
| John Bailey | M | 65 | 6 years | |
| Alex Popa | M | - |
Stanford University
| 4 years |
| Christopher James Wilson | M | - |
Stanford University
| 3 years |
| Ming Chun Sun | M | 52 |
Stanford University
| 5 years |
| David Miller | M | - |
Stanford University
| 3 years |
| Ghazi Al-Rawi | M | - |
Stanford University
| 6 years |
| Ash Upadhyaya | M | 45 |
Stanford University
| 2 years |
| David Topham | M | - |
Stanford University
| 4 years |
| Lou Fernandes | M | - |
Stanford University
| 2 years |
| Stephen van Horne | M | - |
Stanford University
| 2 years |
| Matthew E. Spiegelman | M | - |
Stanford University
| 5 years |
| Benjamin Perdue Olding | M | - |
Stanford University
| 6 years |
| Timothy Stonehocker | M | 43 |
Stanford University
| 4 years |
| Jeremy Ginsberg | M | - |
Stanford University
| 5 years |
| Christopher E Olin | M | - |
Stanford University
| 7 years |
| Elizabeth Xie | M | - |
Stanford University
| 6 years |
| Sharon Barbari | F | 70 | 2 years | |
| Dustin Espersen | M | - |
Stanford University
| 5 years |
| Lisa Hersch | F | - |
Stanford University
| 2 years |
| Karen Martell | F | - |
Stanford University
| 4 years |
| Justin Wilson | M | 42 |
Stanford University
| 5 years |
| Blake F. Brazeal | M | - | 4 years | |
| Sally Madsen | F | - |
Stanford University
| 6 years |
| Balaji S. Srinivasan | M | - |
Stanford University
| 6 years |
| Y. Dan Rubinstein | M | - |
Stanford University
| 6 years |
| Elizabeth Wademan | F | 48 | 6 years | |
| Yvonne Gavrilis | F | - |
Stanford University
| 5 years |
| David Kabakoff | M | 76 | 9 years | |
| Laudan N. Fariborz | F | - |
Stanford University
| 7 years |
| George Parker | M | 85 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 13 years |
| David Leon Mitchell | M | 59 |
Software AG USA, Inc.
Software AG USA, Inc. Packaged SoftwareTechnology Services Software AG USA, Inc. provides infrastructure software solutions. It serves the banking, education, energy, insurance, retail, and telecommunication sectors. The company is headquartered in Reston, VA. | 9 years |
| Melanie Haratunian | F | 64 | 14 years | |
| Stephen N. Rosenfield | M | 74 | 4 years | |
| Douglas W. McNitt | M | 59 |
Software AG USA, Inc.
Software AG USA, Inc. Packaged SoftwareTechnology Services Software AG USA, Inc. provides infrastructure software solutions. It serves the banking, education, energy, insurance, retail, and telecommunication sectors. The company is headquartered in Reston, VA. | 7 years |
| Robin Steele | F | 68 | 10 years | |
| Howard Allan Simon | M | 65 | - | |
| Jason Michael Brady | M | 56 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | 1 years |
| Cathleen Phillips Davis | F | 70 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 2 years |
| Naomi Seligman | F | 86 | - | |
| Timothy Weller | M | 59 | 3 years | |
| Philip Satre | M | 74 |
Stanford University
| 4 years |
| Timothy Patrick Lynch | M | 54 | 3 years | |
| John G. Curd | M | 78 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 4 years |
| Peter Kight | M | 68 | 8 years | |
| William Ringo | M | 78 | - | |
| Gina Sanchez | F | - |
Stanford University
| 5 years |
| Neil Labatte | M | 65 | 6 years | |
| David Hoffmann | M | 79 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | - |
| George Tidmarsh | M | 64 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 4 years |
| Ziang Tony Ngo | M | 44 |
Stanford University
| 4 years |
| J. Sherman | M | 59 | 7 years | |
| Matthew Pauker | M | - |
Stanford University
| 4 years |
| Andrew Astor | M | 67 |
Software AG USA, Inc.
Software AG USA, Inc. Packaged SoftwareTechnology Services Software AG USA, Inc. provides infrastructure software solutions. It serves the banking, education, energy, insurance, retail, and telecommunication sectors. The company is headquartered in Reston, VA. | 2 years |
| Scott A. Baker | M | - |
Stanford University
| 4 years |
| Jennifer W. Kheng | F | - |
Stanford University
| 4 years |
| Jessica Baron | F | 48 |
Stanford University
| 4 years |
| Guillaume Horel | M | - |
Stanford University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Halter
- Personal Network
